Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 51

References for PMC Articles for PubMed (Select 22647704)

1.

Vpu mediates depletion of interferon regulatory factor 3 during HIV infection by a lysosome-dependent mechanism.

Doehle BP, Chang K, Rustagi A, McNevin J, McElrath MJ, Gale M Jr.

J Virol. 2012 Aug;86(16):8367-74. doi: 10.1128/JVI.00423-12. Epub 2012 May 16.

2.

Induction of innate immune responses by SIV in vivo and in vitro: differential expression and function of RIG-I and MDA5.

Co JG, Witwer KW, Gama L, Zink MC, Clements JE.

J Infect Dis. 2011 Oct 1;204(7):1104-14. doi: 10.1093/infdis/jir469.

3.

Immune signaling by RIG-I-like receptors.

Loo YM, Gale M Jr.

Immunity. 2011 May 27;34(5):680-92. doi: 10.1016/j.immuni.2011.05.003. Review.

4.

TRIM5 is an innate immune sensor for the retrovirus capsid lattice.

Pertel T, Hausmann S, Morger D, Züger S, Guerra J, Lascano J, Reinhard C, Santoni FA, Uchil PD, Chatel L, Bisiaux A, Albert ML, Strambio-De-Castillia C, Mothes W, Pizzato M, Grütter MG, Luban J.

Nature. 2011 Apr 21;472(7343):361-5. doi: 10.1038/nature09976.

5.

HIV infection of dendritic cells subverts the IFN induction pathway via IRF-1 and inhibits type 1 IFN production.

Harman AN, Lai J, Turville S, Samarajiwa S, Gray L, Marsden V, Mercier SK, Jones K, Nasr N, Rustagi A, Cumming H, Donaghy H, Mak J, Gale M Jr, Churchill M, Hertzog P, Cunningham AL.

Blood. 2011 Jul 14;118(2):298-308. doi: 10.1182/blood-2010-07-297721. Epub 2011 Mar 16. Erratum in: Blood. 2011 Dec 22;118(26):6992. Mercier, Sarah [corrected to Mercier, Sarah K].

6.

Abortive HIV infection mediates CD4 T cell depletion and inflammation in human lymphoid tissue.

Doitsh G, Cavrois M, Lassen KG, Zepeda O, Yang Z, Santiago ML, Hebbeler AM, Greene WC.

Cell. 2010 Nov 24;143(5):789-801. doi: 10.1016/j.cell.2010.11.001. Erratum in: Cell. 2014 Feb 27;156(5):1112-3.

7.

RIG-I-mediated antiviral signaling is inhibited in HIV-1 infection by a protease-mediated sequestration of RIG-I.

Solis M, Nakhaei P, Jalalirad M, Lacoste J, Douville R, Arguello M, Zhao T, Laughrea M, Wainberg MA, Hiscott J.

J Virol. 2011 Feb;85(3):1224-36. doi: 10.1128/JVI.01635-10. Epub 2010 Nov 17.

8.

The cytosolic exonuclease TREX1 inhibits the innate immune response to human immunodeficiency virus type 1.

Yan N, Regalado-Magdos AD, Stiggelbout B, Lee-Kirsch MA, Lieberman J.

Nat Immunol. 2010 Nov;11(11):1005-13. doi: 10.1038/ni.1941. Epub 2010 Sep 26.

9.

A cryptic sensor for HIV-1 activates antiviral innate immunity in dendritic cells.

Manel N, Hogstad B, Wang Y, Levy DE, Unutmaz D, Littman DR.

Nature. 2010 Sep 9;467(7312):214-7. doi: 10.1038/nature09337. Erratum in: Nature. 2011 Feb 17;470(7334):424.

10.

Immune evasion and counteraction of restriction factors by HIV-1 and other primate lentiviruses.

Kirchhoff F.

Cell Host Microbe. 2010 Jul 22;8(1):55-67. doi: 10.1016/j.chom.2010.06.004. Review.

11.

The great escape: viral strategies to counter BST-2/tetherin.

Douglas JL, Gustin JK, Viswanathan K, Mansouri M, Moses AV, Früh K.

PLoS Pathog. 2010 May 13;6(5):e1000913. doi: 10.1371/journal.ppat.1000913. Review.

12.

The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors.

Kawai T, Akira S.

Nat Immunol. 2010 May;11(5):373-84. doi: 10.1038/ni.1863. Epub 2010 Apr 20. Review.

PMID:
20404851
13.

IPS-1 is essential for the control of West Nile virus infection and immunity.

Suthar MS, Ma DY, Thomas S, Lund JM, Zhang N, Daffis S, Rudensky AY, Bevan MJ, Clark EA, Kaja MK, Diamond MS, Gale M Jr.

PLoS Pathog. 2010 Feb 5;6(2):e1000757. doi: 10.1371/journal.ppat.1000757.

14.

Recognition of viruses by cytoplasmic sensors.

Wilkins C, Gale M Jr.

Curr Opin Immunol. 2010 Feb;22(1):41-7. doi: 10.1016/j.coi.2009.12.003. Epub 2010 Jan 12. Review.

15.

HIV-1 accessory protein Vpu internalizes cell-surface BST-2/tetherin through transmembrane interactions leading to lysosomes.

Iwabu Y, Fujita H, Kinomoto M, Kaneko K, Ishizaka Y, Tanaka Y, Sata T, Tokunaga K.

J Biol Chem. 2009 Dec 11;284(50):35060-72. doi: 10.1074/jbc.M109.058305. Epub 2009 Oct 16.

16.

Human immunodeficiency virus type 1 mediates global disruption of innate antiviral signaling and immune defenses within infected cells.

Doehle BP, Hladik F, McNevin JP, McElrath MJ, Gale M Jr.

J Virol. 2009 Oct;83(20):10395-405. doi: 10.1128/JVI.00849-09. Epub 2009 Aug 12.

17.

Human immunodeficiency virus, restriction factors, and interferon.

Neil S, Bieniasz P.

J Interferon Cytokine Res. 2009 Sep;29(9):569-80. doi: 10.1089/jir.2009.0077. Review.

18.

Vpu directs the degradation of the human immunodeficiency virus restriction factor BST-2/Tetherin via a {beta}TrCP-dependent mechanism.

Douglas JL, Viswanathan K, McCarroll MN, Gustin JK, Früh K, Moses AV.

J Virol. 2009 Aug;83(16):7931-47. doi: 10.1128/JVI.00242-09. Epub 2009 Jun 10.

19.

Vpu antagonizes BST-2-mediated restriction of HIV-1 release via beta-TrCP and endo-lysosomal trafficking.

Mitchell RS, Katsura C, Skasko MA, Fitzpatrick K, Lau D, Ruiz A, Stephens EB, Margottin-Goguet F, Benarous R, Guatelli JC.

PLoS Pathog. 2009 May;5(5):e1000450. doi: 10.1371/journal.ppat.1000450. Epub 2009 May 29.

20.

Divergent TLR7 and TLR9 signaling and type I interferon production distinguish pathogenic and nonpathogenic AIDS virus infections.

Mandl JN, Barry AP, Vanderford TH, Kozyr N, Chavan R, Klucking S, Barrat FJ, Coffman RL, Staprans SI, Feinberg MB.

Nat Med. 2008 Oct;14(10):1077-87. doi: 10.1038/nm.1871. Epub 2008 Sep 14.

PMID:
18806803
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk